Project Grant R01EY035717
Award Date
9/30/24
Completion Date
4/30/28
Dollars Obligated
$685K
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
The National Eye Institute (NEI) awarded a $425,000 Project Grant (CFDA 93.867 - Vision Research) to the Massachusetts Eye and Ear Infirmary to conduct large-scale genetic profiling of childhood glaucoma in India. The project aims to identify causal mutations in known childhood glaucoma genes and discover novel genes responsible for this debilitating disease. The research will leverage whole exome sequencing data from 480 childhood glaucoma patients and family members in India to apply quality...
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) provides $250,500.00 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to develop a genome editing approach to correct the splicing mutation that causes Familial Dysautonomia (FD) and rescue retinal degeneration in FD patients. The key products and services to be delivered include: Developing and customizing base editors capable of precisely correcting the ELP1 mutation...
This $1,789,542 Project Grant award from the National Eye Institute (NEI), under the CFDA 93.867 Vision Research program, supports research to characterize the role of modular super-enhancers in regulating the expression of key transcription factor genes during retinal development in mice and humans. The awardee, St. Jude Children's Research Hospital, will leverage their Integrated Retinal Nucleome Database (IRNDB v.2) to identify developmental stage- and cell type-specific...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), will provide $1,241,223 to the University of Pittsburgh to investigate the genetic and epigenetic mechanisms underlying retinal development and congenital vision disorders. The research aims to: Dissect the molecular, cellular, and genomic effects of genetic mutations on retinal development using mouse models. Elucidate how transcription factors wire the chromatin...
This Project Grant award from the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) is funding research to develop an innovative gene therapy approach using self-amplifying and self-splicing RNA technologies. The $346,500 award, spanning September 2024 to September 2026, aims to evaluate the longevity, immunogenicity, and potential in vivo side effects of this novel mRNA-based therapy for treating inherited retinal dystrophies. The award recipient, The...
The National Eye Institute (NEI) has awarded a $592,457 Project Grant (CFDA 93.867 - Vision Research) to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to characterize the response features of intrinsically photosensitive retinal ganglion cells (ipRGCs) and understand how they shape signals sent from ipRGCs to the brain. The award period is from September 30, 2024 to August 31, 2029. The research aims to strengthen the basic understanding of ipRGCs, sensory...
This federal Project Grant award of $715,098 from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) aims to enhance glaucoma risk prediction through advanced genomics and machine learning. The key products and services to be delivered include: Improving polygenic risk score (PRS) performance for glaucoma by leveraging natural language processing techniques and electronic health record data from over 68,000 patients to extract refined glaucoma phenotypes. The...
This $435,052 Project Grant award from the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) supports research to elucidate the regulatory mechanisms that specify different subtypes of photoreceptor neurons for color vision. The University of Massachusetts Boston is the primary awardee, conducting this 4-year project to investigate how a binary switch controls the blue- vs. green-sensitive photoreceptor fate decision through differential regulation of the...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), aims to develop a rapid, culture-independent diagnostic approach for detecting pathogens and antimicrobial resistance in sight-threatening ocular infections. The $425,000 award, effective August 1, 2024 through July 31, 2029, will support the Massachusetts Eye and Ear Infirmary in creating a metagenomic sequencing-based platform that uses portable nanopore sequencers to provide...
The National Eye Institute (NEI) awarded a $638,267 Project Grant (CFDA 93.867 - Vision Research) to The Schepens Eye Research Institute, Inc. to develop a retina-specific treatment for familial dysautonomia (FD), a severe neurodegenerative disorder that causes progressive blindness. The project aims to comprehensively evaluate systemic and local therapeutic approaches to rescue visual function in FD, including genetic or pharmacological modulation of the ELP1 gene and genetic supplementation of...